title: Pemphigus, pregnancy, and plasmapheresis.
abstract: Pemphigus vulgaris (PV) is an autoimmune blistering disorder that usually occurs in the fifth and sixth decades of life but may occur at younger ages and during pregnancy. Circulating intercellular antibodies directed at desmosomal proteins may cross the placenta and place children at risk for neonatal pemphigus (NP). We describe the case of a pregnant woman with PV treated successfully with a combination of systemic corticosteroids and plasmapheresis. The possibility of PV should be considered in any pregnant woman with a worsening, widespread, mucocutaneous, blistering disease. Plasmapheresis offers a useful alternative to immunosuppressive therapy in the setting of pregnancy.
authors.affiliation: State University of New York at Buffalo, USA.
authors.forename: Sherry
authors.initials: S
authors.lastname: Shieh
authors.forename: Yisheng V
authors.initials: YV
authors.lastname: Fang
authors.forename: Joanne L
authors.initials: JL
authors.lastname: Becker
authors.forename: Allison
authors.initials: A
authors.lastname: Holm
authors.forename: Ernest H
authors.initials: EH
authors.lastname: Beutner
authors.forename: Thomas N
authors.initials: TN
authors.lastname: Helm
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010392:Pemphigus / Q000151:congenital / Q000473:pathology / Q000628:therapy*; D010956:Plasmapheresis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000473:pathology / Q000628:therapy*